Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 19, Number 9—September 2013

CME ACTIVITY

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

Earning CME Credit

To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and earn continuing medical education (CME) credit, please go to www.medscape.org/journal/eid. Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You must be a registered user on Medscape.org. If you are not registered on Medscape.org, please click on the New Users: Free Registration link on the left hand side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@webmd.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to http://www.ama-assn.org/ama/pub/category/2922.html. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the certificate and present it to your national medical association for review.

Article Title: Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

CME Questions

1. There are reports of an outbreak of mumps in your community. As you prepare to see patients who may be infected, what should you consider regarding mumps?

A. Two doses of the measles-mumps-rubella (MMR) vaccine provides over 99% protection against mumps

B. Mumps is only communicable after the onset of parotitis

C. Up to one-quarter of individuals infected with mumps virus may be asymptomatic

D. Public health policies in schools effectively eliminate the risk of the spread of mumps

2. You begin to receive phone calls from patients interested in a third dose of MMR as postexposure prophylaxis. What is the policy of the Advisory Committee on Immunization Practices (ACIP) regarding postexposure prophylaxis with MMR?

A. It should be administered to household contacts only

B. It should be administered to children between the ages of 5 and 12 years only

C. It should be applied broadly in affected communities

D. It should not be used at all

3. You see a 4-year-old boy in your clinic that day who appears to have mumps. Which of the following statements regarding the presentation of cases of mumps in the current study is most accurate?

A. The median age of index case-patients was 9 years

B. Most cases had not received 2 doses of MMR

C. Nearly all secondary case-patients who did not receive postexposure prophylaxis were young children

D. Secondary cases were far more common in households in which the index case-patient had received fewer than 2 doses of MMR

4. What was the main result of using MMR as postexposure prophylaxis against mumps in the current study?

A. MMR was not associated with a numerical or statistical benefit

B. MMR was associated with a lower rate of secondary cases of mumps, but the result was not statistically significant

C. MMR significantly reduced the risk of secondary cases of mumps

D. MMR caused more cases of mumps than it prevented

Activity Evaluation

1. The activity supported the learning objectives.

Strongly Disagree

Strongly Agree

1

2

3

4

5

2. The material was organized clearly for learning to occur.

Strongly Disagree

Strongly Agree

1

2

3

4

5

3. The content learned from this activity will impact my practice.

Strongly Disagree

Strongly Agree

1

2

3

4

5

4. The activity was presented objectively and free of commercial bias.

Strongly Disagree

Strongly Agree

1

2

3

4

5

Article Navigation

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO